Literature DB >> 9813557

Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.

D E Newby1, N E Goodfield, A D Flapan, N A Boon, K A Fox, D J Webb.   

Abstract

OBJECTIVE: To determine directly the contribution of angiotensin II to basal and sympathetically stimulated peripheral arteriolar tone in patients with heart failure.
DESIGN: Parallel group comparison.
SUBJECTS: Nine patients with New York Heart Association grade II-IV chronic heart failure, and age and sex matched controls.
INTERVENTIONS: Forearm plethysmography, lower body negative pressure, local intra-arterial administration of losartan, angiotensin II, and noradrenaline, and estimation of plasma hormone concentrations. MAIN OUTCOME MEASURES: Forearm blood flow responses, plasma hormone concentrations.
RESULTS: Baseline blood pressure, heart rate, and forearm blood flow did not differ between patients and controls. In comparison with the non-infused forearm, losartan did not affect basal forearm blood flow (95% confidence interval -5.5% to +7.3%) or sympathetically stimulated vasoconstriction in controls. However, the mean (SEM) blood flow in patients increased by 13(5)% and 26(7)% in response to 30 and 90 micrograms/min of losartan respectively (p < 0.001). Lower body negative pressure caused a reduction in forearm blood flow of 20(5)% in controls (p = 0.008) and 13(5)% (p = 0.08) in patients (p = 0.007, controls v patients). Blood flow at 90 micrograms/min of losartan correlated with plasma angiotensin II concentration (r = 0.77; p = 0.03). Responses to angiotensin II and noradrenaline did not differ between patients and controls.
CONCLUSIONS: Losartan causes acute local peripheral arteriolar vasodilation in patients with heart failure but not in healthy control subjects. Endogenous angiotensin II directly contributes to basal peripheral arteriolar tone in patients with heart failure but does not augment sympathetically stimulated peripheral vascular tone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813557      PMCID: PMC1728788          DOI: 10.1136/hrt.80.2.134

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  34 in total

1.  Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.

Authors:  P Vallance; J Collier; S Moncada
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

2.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  Dietary salt and blood pressure.

Authors:  G A MacGregor
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

4.  Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure.

Authors:  M A Creager; B M Massie; D P Faxon; S D Friedman; B L Kramer; D A Weiner; T J Ryan; N Topic; C D Melidossian
Journal:  J Am Coll Cardiol       Date:  1985-07       Impact factor: 24.094

5.  Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine.

Authors:  B Rolinski; I Sadri; J Bogner; F D Goebel
Journal:  Res Exp Med (Berl)       Date:  1994

6.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

7.  Effect of angiotensin II on noradrenaline release in the human forearm.

Authors:  S R Goldsmith; T S Rector; A J Bank; M Garr; S H Kubo
Journal:  Cardiovasc Res       Date:  1994-05       Impact factor: 10.787

8.  Contribution of endogenous generation of endothelin-1 to basal vascular tone.

Authors:  W G Haynes; D J Webb
Journal:  Lancet       Date:  1994-09-24       Impact factor: 79.321

9.  Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.

Authors:  T B Levine; M T Olivari; V Garberg; S W Sharkey; J N Cohn
Journal:  Circulation       Date:  1984-03       Impact factor: 29.690

10.  Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

Authors:  W N Leimbach; B G Wallin; R G Victor; P E Aylward; G Sundlöf; A L Mark
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

View more
  2 in total

Review 1.  The acute vascular effects of frusemide in heart failure.

Authors:  P S Jhund; J J McMurray; A P Davie
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

2.  Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.

Authors:  S J Leslie; J C S Spratt; S P McKee; F E Strachan; D E Newby; D B Northridge; M A Denvir; D J Webb
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.